Skip to main navigation Skip to search Skip to main content

25-GU-89-ABS (CA-ALT-803-01-14;QUILT-2.005): A Study of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With Non-Muscle Invasive Bladder Cancer

Grants and Contracts Details

StatusActive
Effective start/end date10/28/25 → 10/28/27

Funding

  • ImmunityBio Incorporated: $42,425.00